PODCAST

SmallCaps Podcast

SmallCaps

Market news & in-depth interviews with ASX-listed small cap companies.

business investing

All Episodes

20:27

Matador Mining's (ASX: MZZ) major drilling program to...

SmallCaps Podcast ·

2021/05/11

Matador Mining (ASX: MZZ) executive chairman Ian Murray joins Small Caps to discuss the company’s 2021 exploration season at its flagship Cape Ray gold project in Newfoundland, Canada. Mr Murray describes the projects as one of the highest-grade undeveloped open pit projects in a first world jurisdiction. The project has 837,000oz gold resource with major upside across its 120km of continuous strike.See omnystudio.com/listener for privacy information.

en-au

18:52

Trigg Mining's (ASX: TMG) maiden SOP inferred...

SmallCaps Podcast ·

2021/05/10

Trigg Mining (ASX: TMG) managing director Keren Paterson joins Small Caps to discuss the company’s maiden resource and updated exploration target for its Lake Throssell sulphate of potash (SOP) project in Western Australia. Ms Paterson said the maiden resource underpins the potential for a sustainable long-term production hub in a tier one location. Work moving forward will involve updating the maiden inferred resource to indicated status and completing a scoping study.See omnystudio.com/listener

en-au

28:30

The everything bubble - is the wealth effect starting...

SmallCaps Podcast ·

2021/04/30

Tony Locantro, investment manager at Alto Capital, joins Small Caps to share his views on what's taking place in the stock market, where opportunity may lay and what might come next.See omnystudio.com/listener for privacy information.

en-au

15:17

AssetOwl (ASX: AO1) targets Australia-wide market for...

SmallCaps Podcast ·

2021/04/27

AssetOwl (ASX: AO1) chief executive officer Geoff Goldsmith joins Small Caps to discuss the company’s growth plans for its “market leading” inspector360 property management platform. Mr Goldsmith noted the platform had been enhanced over the last 12 months and includes critical market leading features. To fund the company’s WA and subsequent Australia-wide roll out plans, AssetOwl recently completed a “strongly oversubscribed” $1.5 million placement.See omnystudio.com/listener for privacy

en-au

15:31

PharmAust (ASX: PAA) progresses flagship Monepantel...

SmallCaps Podcast ·

2021/04/26

PharmAust (ASX: PAA) executive chairman and CEO Dr Roger Aston joins Small Caps to discuss the company’s Monepantel drug and its antiviral potential after laboratory results have consistently shown it can interfere with the proliferation of SARS-CoV2, the virus causing COVID-19. More advanced trials for Monepantel are also underway, where it is being used to treat canine lymphoma. This phase IIb trial is evaluating Monepantel in treatment-naïve B cell lymphoma, with this study still recruiting and

en-au

26:02

Medlab Clinical (ASX: MDC) advances penetration of...

SmallCaps Podcast ·

2021/04/21

Medlab Clinical (ASX: MDC) chief executive officer Dr Sean Hall joins Small Caps to discuss the company’s commercialisation strategy for its NanoCelle drug delivery technology with the European Patent Office recently notifying the company of its intent to grant a patent. Medlab already has a patent in Australia for NanoCelle, with applications also filed in the US, NZ, Singapore and Hong Kong. The company is also progressing its cannabinoid-based drug NanaBis, which is being evaluated in treating

en-au

19:00

EMVision Medical Devices (ASX: EMV) advances its...

SmallCaps Podcast ·

2021/04/20

EMVision Medical Devices (ASX: EMV) executive director and co-founder Scott Kirkland joins Small Caps to discuss the company’s strategy to commercialise its portable medical imaging technology for easy stroke diagnosis. The point-of-care technology is described as “transformative” – providing fast, safe and readily accessed imaging. While initially targeting neurological disorders, EMVision’s plan is to make the technology applicable across the entire body.See omnystudio.com/listener for privacy

en-au

25:57

Lifespot Health (ASX: LSH) progresses...

SmallCaps Podcast ·

2021/04/15

Lifespot Health (ASX: LSH) chief executive officer Matthew Golden joins Small Caps to discuss the company’s cannabis-based medical grade vape devices. Sales of Lifespot’s Medihale device have continued to grow and are underpinned by a partnership with ITSUWA and a supply deal with EC Pharma. The company’s strategy is to unveil “first to market” medically registered and integrated medical cannabis vape delivery systems.See omnystudio.com/listener for privacy information.

en-au

37:59

Australia's property bubble and Tony's stock picks...

SmallCaps Podcast ·

2021/04/14

en-au

21:07

Kin Mining (ASX: KIN) well-funded to advance drilling...

SmallCaps Podcast ·

2021/04/14

Kin Mining (ASX: KIN) managing director Andrew Munckton joins Small Caps to discuss the company’s high-grade exploration results at the Cardinia gold project, with “outstanding” recent assays from the Bruno-Lewis and Cardinia Hill deposits. The next stage of exploration is underpinned by a $12.8 million capital raising during the March quarter. This funding enables Kin to follow-up on other discoveries including the Eagle-Crow prospect, while advancing Bruno-Lewis and Cardinia Hill.See

en-au

23:13

Global Energy Ventures (ASX: GEV) powers ahead with...

SmallCaps Podcast ·

2021/04/11

Global Energy Ventures (ASX: GEV) executive director Martin Carolan joins Small Caps to discuss the company’s plans to commercialise its zero-emission, compressed hydrogen marine shipping solution. Mr Carolan noted the company had announced a scoping study at the start of March that showed its compressed hydrogen shipping supply chain was both technically and economically feasible. This was followed up with the American Bureau of Shipping’s Approval in Principle being granted later that month for

en-au

22:24

K-TIG (ASX: KTG) accelerates expansion plans for...

SmallCaps Podcast ·

2021/04/09

K-TIG (ASX: KTG) managing director Adrian Smith joins Small Caps to discuss the company’s accelerated expansion plans focusing on the US market. During the current quarter, K-TIG expects to secure further US distribution agreements and boost sales in the US through its demonstration site in Pennsylvania. Back in Australia, K-TIG has made inroads into the country’s defence sector with two key manufacturing partnerships in recent weeks.See omnystudio.com/listener for privacy information.

en-au

24:37

Osteopore (ASX: OSX) continues penetrating global...

SmallCaps Podcast ·

2021/04/07

Osteopore (ASX: OSX) chief financial officer Carl Runde joins Small Caps to discuss the company’s breakthrough bioresorbable products which facilitate bone regeneration. The current target markets for Osteopore’s products are worth more than US$103 billion. Compared to current procedures, Osteopore’s bone regeneration products offer improved patient outcomes while also reducing overall healthcare costs.See omnystudio.com/listener for privacy information.

en-au

19:13

Nova Minerals (ASX: NVA) reveals 4.7Moz gold interim...

SmallCaps Podcast ·

2021/04/07

Nova Minerals (ASX: NVA) chief executive officer Christopher Gerteisen joins Small Caps to discuss the company’s ongoing exploration success at its flagship Estelle project in Alaska’s Tintina Province. The company has unveiled an interim resource upgrade of 4.7Moz contained gold for the Korbel Main deposit and expects this to grow substantially with mineralisation remaining open along strike and at depth. To unlock the project’s further potential, Nova is continuing to drill throughout 2021 with a

en-au

22:25

AuKing Mining (ASX: AKN) takes to market the Koongie...

SmallCaps Podcast ·

2021/04/03

AuKing Mining (ASX: AKN) managing director Paul Williams joins Small Caps to discuss the company's $7 million IPO and plans to acquire 75% of the advanced Koongie Park copper-zinc project near Halls Creek in Western Australia. In its IPO, AuKing is hoping to raise up to $7 million with a minimum subscription of $6 million. Koongie Park has already undergone exploration, mine planning and feasibility studies, with AuKing's ultimate goal being to finally bring the project across the line.See

en-au

23:11

Boss Energy (ASX: BOE) to de-risk Honeymoon mine...

SmallCaps Podcast ·

2021/03/30

Boss Energy (ASX: BOE) managing director and chief executive officer Duncan Craib joins Small Caps to discuss the company's strategy on restarting the Honeymoon uranium mine in South Australia. An enhanced feasibility study is close to finishing with results due next quarter. To de-risk the project further, the company recently raised $60 million to acquire a large uranium inventory in the US, which it expects will strengthen its position in offtake and project funding negotiations.See

en-au

38:53

Nuclear power will lead to a cleaner future says...

SmallCaps Podcast ·

2021/03/27

Bannerman Resources (ASX: BMN) chief executive officer Brandon Munro joins small caps to discuss the current state of the uranium market and why nuclear power is the future. Brandon is also the chair of the Nuclear Fuel Demand Working Group. Bannerman describes its Etango uranium project in Namibia as a "world class" uranium asset with a large resource. The project has the added advantage of being situated in an established uranium jurisdiction with access to supporting infrastructure.See

en-au

30:53

Is Australia's artificial economy on the brink of a...

SmallCaps Podcast ·

2021/03/23

en-au

25:03

Lotus Resources (ASX: LOT) readies Kayelekera uranium...

SmallCaps Podcast ·

2021/03/16

Lotus Resources (ASX: LOT) managing director Keith Bowes joins Small Caps to discuss the company’s plans in reviving Paladin Energy’s previous Kayelekera uranium mine in Malawi. Lotus estimates minimal capital expenditure is required to bring the mine back online and has also identified rare earth potential at the project. At Kayelekera, Lotus expects to produce 3Mlb or uranium annually with a feasibility study due to finish in the first half of next year.See omnystudio.com/listener for privacy

en-au

20:09

Alterity Therapeutics' (ASX: ATH) phase 2 clinical...

SmallCaps Podcast ·

2021/03/11

Alterity Therapeutics (ASX: ATH) chief executive officer Dr David Stamler joins Small Caps to discuss the company’s lead drug candidate ATH434, which has been developed to combat the side effects of Parkinsonian disorders. The disorder includes multiple system atrophy (MSA), which Alterity is focused on treating with ATH434 in clinical trials. Dr Stamler points out there is a substantial unmet need for MSA treatments with forecast potential annual sales of ATH434 in the US of $550-725 million. See

en-au

690 results

SmallCaps Podcast

All Episodes

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...